Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$737M |
| 2 |
Invesco S&P 500 Revenue ETF
RWL
|
+$669M |
| 3 |
Bank of America
BAC
|
+$513M |
| 4 |
Amazon
AMZN
|
+$510M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$482M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Pure Value ETF
RPV
|
+$491M |
| 2 |
Trade Desk
TTD
|
+$466M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$373M |
| 4 |
Eli Lilly
LLY
|
+$367M |
| 5 |
Williams-Sonoma
WSM
|
+$295M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.41% |
| 2 | Financials | 13.31% |
| 3 | Industrials | 11.28% |
| 4 | Healthcare | 10.55% |
| 5 | Consumer Discretionary | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Nomad Foods
NOMD
$1.59B
| $1.15M | ﹤0.01% |
58,720
-4,709
| -7% | -$86K |
|
2702
Kymera Therapeutics
KYMR
$9.48B
| $1.15M | ﹤0.01% |
42,075
+11,343
| +37% | +$413K |
|
2703
Smith & Wesson
SWBI
$636M
| $1.15M | ﹤0.01% |
123,139
-8,637
| -7% | -$89K |
|
2704
International General Insurance
IGIC
$1.13B
| $1.15M | ﹤0.01% |
43,599
+10,954
| +34% | +$278K |
|
2705
Teekay
TK
$1.03B
| $1.15M | ﹤0.01% |
174,317
-49,160
| -22% | -$340K |
|
|
EMF
2706
Templeton Emerging Markets Fund
EMF
$332M
| $1.14M | ﹤0.01% |
88,994
-2,736
| -3% | -$34.6K |
|
2707
Stratasys
SSYS
$767M
| $1.14M | ﹤0.01% |
116,028
-3,909
| -3% | -$40.2K |
|
2708
Orthofix Medical
OFIX
$424M
| $1.14M | ﹤0.01% |
69,600
-5,377
| -7% | -$94.4K |
|
|
ACP
2709
abrdn Income Credit Strategies Fund
ACP
$646M
| $1.13M | ﹤0.01% |
192,197
+25,234
| +15% | +$152K |
|
2710
AngioDynamics
ANGO
$651M
| $1.13M | ﹤0.01% |
119,929
+680
| +0.6% | +$7.15K |
|
2711
Peapack-Gladstone Financial
PGC
$820M
| $1.12M | ﹤0.01% |
39,575
-8,006
| -17% | -$251K |
|
2712
Designer Brands
DBI
$311M
| $1.12M | ﹤0.01% |
306,053
+8,911
| +3% | +$41.9K |
|
|
MLNK
2713
DELISTED
MeridianLink
MLNK
| $1.12M | ﹤0.01% |
60,205
+30,437
| +102% | +$588K |
|
|
ECF
2714
Ellsworth Growth & Income Fund
ECF
$178M
| $1.12M | ﹤0.01% |
122,838
+24,994
| +26% | +$242K |
|
2715
Iovance Biotherapeutics
IOVA
$3.05B
| $1.11M | ﹤0.01% |
334,257
+112,329
| +51% | +$579K |
|
2716
RLX Technology
RLX
$2.47B
| $1.11M | ﹤0.01% |
590,243
+12,834
| +2% | +$28.5K |
|
2717
Oil States International
OIS
$536M
| $1.11M | ﹤0.01% |
215,295
-29,482
| -12% | -$155K |
|
2718
Business First Bancshares
BFST
$1.05B
| $1.11M | ﹤0.01% |
45,392
+2,064
| +5% | +$53.2K |
|
|
JAMF
2719
DELISTED
Jamf
JAMF
| $1.1M | ﹤0.01% |
90,809
+28,279
| +45% | +$405K |
|
|
PLYM
2720
DELISTED
Plymouth Industrial REIT
PLYM
| $1.1M | ﹤0.01% |
67,509
-84,260
| -56% | -$1.42M |
|
2721
Tilray
TLRY
$637M
| $1.1M | ﹤0.01% |
167,334
-36,620
| -18% | -$339K |
|
2722
Lifestance Health
LFST
$4.67B
| $1.09M | ﹤0.01% |
164,384
+2,238
| +1% | +$17K |
|
|
SOL
2723
DELISTED
Emeren Group
SOL
| $1.09M | ﹤0.01% |
695,245
-96,903
| -12% | -$169K |
|
2724
Grupo Aeroportuario del Sureste
ASR
$8.24B
| $1.09M | ﹤0.01% |
3,985
-7,361
| -65% | -$2.01M |
|
2725
Blink Charging
BLNK
$85.6M
| $1.09M | ﹤0.01% |
1,185,794
+198,350
| +20% | +$230K |
|
Similar funds
Invesco's Q1 2025 Portfolio in Review
As of Q1 2025, Invesco held 3,856 positions worth $528B, down 2.4% from $541B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Invesco's Q1 2025 filing shows 117 new, 1,793 increased, 1,749 reduced and 89 closed positions. Its largest new stake was Invesco Managed Futures Strategy ETF: 4,184,000 shares worth $206M. The largest sale was Invesco S&P 500 Pure Value ETF, an estimated $491M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.
- Invesco's largest Q1 2025 buy was Invesco Managed Futures Strategy ETF: 4,184,000 shares worth $206M.
- Invesco added most to Tesla in Q1 2025, an estimated $737M increase.
- Invesco's biggest Q1 2025 reduction was Invesco S&P 500 Pure Value ETF, cutting an estimated $491M.
- Invesco fully exited ENLINK MIDSTREAM, LLC in Q1 2025, selling an estimated $281M.
- Invesco's ten largest holdings make up 17% of its $528B portfolio in Q1 2025.
- Invesco opened 117 new positions and closed 89 in Q1 2025.
- Invesco's portfolio value fell 2.4% quarter-over-quarter to $528B.
Based on Invesco's 13F filing for Q1 2025, filed 12 May 2025.